In multivariate analysis; a decrease in the AFP to 101‐499 was associated with a >2‐fold reduction in post‐transplant mortality (P = .01) and a nearly 3‐fold reduction in HCC recurrence (P = .02). Here, AFP is linked to hepatocellular carcinoma.